Oct 12 close
H. B. Fuller priced an $850 million private offering of senior unsecured notes carrying a 7.625% coupon to finance its planned acquisition of Advanced Medical Solutions Group plc, a move aimed at extending the company's specialty chemicals business into healthcare applications. The company is also pursuing manufacturing improvement under its Project Quantum Leap initiative. Despite the deal and financing news, the shares have declined, and a director separately purchased 10,000 shares at $50 each through a trust.
FUL closed at $49.33, down 0.5%, sitting below both its 50-day average of $54.43 and 200-day average of $59.07, with the 50-day also below the 200-day. The stock's one-month return stands at -4.4%, its six-month return at -23.6%, and it trades near its 52-week low of $46.70 against a 52-week high of $68.63. The GekkoIndex reads 67.4, placing it in the Accumulation zone, while the price sits 25.7% below Gekko Fair Value of $66.38.
The next earnings date falls on 13 January 2027, outside the typical 20-trading-day window. Over the last 90 days, insiders made 8 open-market purchases totaling $1,137,659. Four analysts covering the stock all rate it a buy, with a consensus target of $68.29. Seasonality from this point in the calendar has averaged a 5.6% gain over the next 20 trading days across 5 years, rising in 4 of them, worth noting alongside the current trend and valuation gap.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
H. B. Fuller scores 5 supportive, 0 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
5 supportive0 mixed1 headwind
Below 50 and 200-day
Close $49.33 is below the 50-day ($54.43) and 200-day ($59.07) averages, and the 50-day is below the 200-day.
See the chart67.4, Accumulation
Reading 67.4 is in the Accumulation zone.
See the GekkoIndex25.7% below
Price is 25.7% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: 8 open-market insider purchases.
See smart moneyReports in 93 days
Next report Jan 13, 2027, 93 days away — outside a typical 20-trading-day hold.
See earnings+5.6% on average
From this point in the calendar, the next 20 trading days averaged +5.6% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
H. B. Fuller closed at $49.33 on Oct 12, 2026, −15.2% over the past year, inside a 52-week range of $46.70 to $68.63.
Use the left and right arrow keys to read daily values.
Put FUL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
H. B. Fuller develops, produces and sells adhesives, sealants, coatings, polymers, tapes, encapsulants and other specialty chemical products. Its offerings are built for use in packaging, hygiene and medical goods, durable assembly, transportation, electronics, construction and related applications, and the company is recognized for this broad range of bonding and sealing materials.
The business is structured into three segments. One covers specialty industrial adhesives for packaging, converting, nonwoven, hygiene and medical or beauty uses. Another supplies high performance industrial adhesives to markets such as durable assembly, wood and textile work, transportation, electronics, clean energy, aerospace and defense, appliances, heavy machinery and insulating glass. A third focuses on products for commercial roofing, HVAC and insulation work, along with caulks and sealants for consumers and professional trades. Customers are reached both directly and through distributors and retailers across North America, Latin America, Europe, India, the Middle East, Africa and the Asia Pacific.
H. B. Fuller traces its founding to 1887 and is based in Saint Paul, Minnesota. Its shares are listed on the NYSE under the ticker FUL.
H. B. Fuller’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 67.4, in the Accumulation zone, up 1.1 points over five sessions.
Up 1.1 points over five sessions.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 58 | 0.0% | +2.4% | ||
| Accumulation (current zone) | 265 | +0.6% | +1.0% | ||
| Neutral | 342 | −0.8% | −2.8% | ||
| Distribution | 16 | −3.0% | −4.3% | ||
| Selling | 1 | Too few readings yet | |||
Average FUL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.2% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
H. B. Fuller trades 25.7% below Gekko Fair Value of $66.38, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what H. B. Fuller shares are worth, recalculated every trading day.
$66.38
Gekko Fair Value, Oct 10, 2026
25.7% Undervalued
At the end of Aug 2026 the price was 22.4% below the estimate.
Insiders filed 8 open-market purchases in H. B. Fuller worth $1.14M, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
$1.14Min 8 open-market purchases
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 8 | BAILLY R JEFFREY director | Purchase | $500K |
| Oct 1 | Happe Michael J director | Purchase | $99K |
| Sep 30 | Zaheer Srilata director | Purchase | $98K |
| Sep 30 | Rasmussen Trangsrud Teresa J director | Purchase | $75K |
| Sep 30 | Lauber Charles T director | Purchase | $100K |
From Form 4 filings, dated to when each was filed.
No trades in FUL were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
H. B. Fuller has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds FUL.
H. B. Fuller reports on Jan 13, 2027 (93 days away), and beat the EPS estimate in 6 of its last 8 reports.
Jan 13, 2027
93 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Sep 23, 2026 | $1.52 est $1.47 | $938.2M est $945.6M | −2.1% |
| Jun 24, 2026 | $1.41 est $1.37 | $950.3M est $924.8M | −1.9% |
| Mar 25, 2026 | $0.57 est $0.56 | $770.8M est $785.0M | +7.1% |
| Jan 14, 2026 | $1.28 est $1.24 | $894.8M est $902.5M | −4.2% |
| Sep 24, 2025 | $1.26 est $1.24 | $892.0M est $895.8M | −4.4% |
| Jun 25, 2025 | $1.18 est $1.10 | $898.1M est $900.0M | +9.0% |
| Mar 26, 2025 | $0.24 est $0.40 | $788.7M est $769.0M | +7.0% |
| Jan 15, 2025 | $0.92 est $1.24 | $923.3M est $814.3M | −2.4% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for H. B. Fuller is $68.29, +38.4% from the last close, from 4 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 4 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 29 | Deutsche Bank | $62 | +25.7% |
| Sep 28 | J.P. Morgan | $66 | +33.8% |
| Sep 25 | Citi | $63 | +27.7% |
| Sep 25 | Robert W. Baird | $65 | +31.8% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, H. B. Fuller averaged +5.6% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +3.1% | 4 of 5 |
| Next 10 trading days | +1.7% | 3 of 5 |
| Next 15 trading days | +2.2% | 3 of 5 |
| Next 20 trading days | +5.6% | 4 of 5 |
| Next 30 trading days | +8.5% | 4 of 5 |
For scale, FUL’s typical 20-trading-day move in either direction is about 4.9%.
H. B. Fuller’s market cap is $2.65B, with a P/E ratio of 14.1 and revenue of $3.55B over the last twelve months.
Coverage of H. B. Fuller this week reads neutral: 0 positive, 5 neutral and 1 negative headlines.
H. B. Fuller’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| SHWSherwin-Williams | Accumulation | 6.3% above |
| PPGPPG Industries | Accumulation | 15.6% below |
| RPMRPM International | Accumulation | 14.8% below |
| AXTAAxalta Coating Systems | Accumulation | 24.0% below |
| CSWCSW Industrials | Accumulation | 4.0% above |
| AZZAZZ | Neutral | 15.1% below |
A peer links to its own page where one exists.
H. B. Fuller’s market cap is $2.65B at the Oct 12, 2026 close of $49.33, with 53.83M shares outstanding. The shares trade on a P/E ratio of 14.1.
The consensus analyst 12-month price target for H. B. Fuller is $68.29, +38.4% from the last close. Of the 4 firms that rated the stock in the last 90 days, 4 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate H. B. Fuller is undervalued: the Oct 12, 2026 close of $49.33 is 25.7% below Gekko Fair Value of $66.38. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
H. B. Fuller is expected to report on Jan 13, 2027 (93 days away). Analysts expect earnings of $1.38 per share on revenue of $946.4M. H. B. Fuller beat the earnings estimate in 6 of its last 8 reports, moving 4.8% on average across the report.
H. B. Fuller’s 52-week high is $68.63 and its 52-week low is $46.70; it closed at $49.33 on Oct 12, 2026, −15.2% over the past year. Over the last five years the shares peaked at $87.67 on Jul 31, 2024.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 5 of the 6 items with data read as supportive (gekkoindex, fair value, smart money, earnings risk and seasonality) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.